Engineering of smart nanostructured lipid carriers encapsulated in gold nanocomposites and camptothecin for synergistic photothermal and chemotherapy treatment of ovarian cancer
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Gold and Silver Nanoparticles Synthesis and Applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (50)
Show source-provided references
1. Chandra A, Pius C, Nabeel M, Nair M, Vishwanatha JK, Ahmad S, Basha R (2019) Ovarian cancer: current status and strategies for improving therapeutic outcomes. Cancer Med 8:7018–703110.1002/cam4.2560 ↗
2. Pokhriyal R, Hariprasad R, Kumar L, Hariprasad G (2019) Chemotherapy resistance in advanced ovarian cancer patients. Biomark Cancer. https://doi.org/10.1177/1179299X1986081510.1177/1179299X19860815 ↗
3. Kurnit KC, Fleming GF, Lengyel E (2021) Updates and new options in advanced epithelial ovarian cancer treatment. Obstet Gynecol 137:10810.1097/AOG.0000000000004173 ↗
4. Barani M, Bilal M, Sabir F, Rahdar A, Kyzas GZ (2021) Nanotechnology in ovarian cancer: diagnosis and treatment. Life Sci 266:11891410.1016/j.lfs.2020.118914 ↗
5. Lee J, Minasian L, Kohn EC (2019) New strategies in ovarian cancer treatment. Cancer 125:4623–462910.1002/cncr.32544 ↗
6. Gaona-Luviano P, Medina-Gaona LA, Magaña-Pérez K (2020) Epidemiology of ovarian cancer. Chin Clin Oncol 9:4710.21037/cco-20-34 ↗
7. Zeb A, Gul M, Nguyen T-T-L, Maeng H-J (2022) Controlled release and targeted drug delivery with poly (lactic-co-glycolic acid) nanoparticles: Reviewing two decades of research. J Pharm Investig 52:683–72410.1007/s40005-022-00584-w ↗
8. Sun R, Xiang J, Zhou Q, Piao Y, Tang J, Shao S, Zhou Z, Bae YH, Shen Y (2022) The tumor EPR effect for cancer drug delivery: current status, limitations, and alternatives. Adv Drug Deliv Rev 191:11461410.1016/j.addr.2022.114614 ↗
9. Xu J, Shamul JG, Kwizera EA, He X (2022) Recent advancements in mitochondria-targeted nanoparticle drug delivery for cancer therapy. Nanomaterials 12:74310.3390/nano12050743 ↗
10. Wang Q, He Z, Zhu H, Gao W, Zhang N, Li J, Yan J, He B, Ye X (2022) Targeting drug delivery and efficient lysosomal escape for chemo-photodynamic cancer therapy by a peptide/DNA nanocomplex. J Mater Chem B 10:438–44910.1039/D1TB02441H ↗
11. Itoo AM, Vemula SL, Gupta MT, Giram MV, Kumar SA, Ghosh B, Biswas S (2022) Multifunctional graphene oxide nanoparticles for drug delivery in cancer. J Control Release 350:26–5910.1016/j.jconrel.2022.08.011 ↗
12. Iravani S, Varma RS (2022) Nanosponges for drug delivery and cancer therapy: recent advances. Nanomaterials 12:244010.3390/nano12142440 ↗
13. Kalashgrani MY, Javanmardi N (2022) Multifunctional Gold nanoparticle: as novel agents for cancer treatment. Adv Appl NanoBio-Technol 3:1–6
14. Jones T, Davison G, Jeong H-H, Lee T-C (2022) Engineered gold nanoparticles for photothermal applications. Phototherm Nanomater 54:3310.1039/9781839165177-00033 ↗
15. Zhang R, Qin X, Lu J, Xu H, Zhao S, Li X, Yang C, Kong L, Guo Y, Zhang Z (2023) Chemodynamic/photothermal synergistic cancer immunotherapy based on yeast microcapsule-derived Au/Pt nanoparticles. ACS Appl Mater Interfaces 15:24134–2414810.1021/acsami.3c02646 ↗
16. Shabani L, Kasaee SR, Chelliapan S, Abbasi M, Khajehzadeh H, Dehghani FS, Firuzyar T, Shafiee M, Amani AM, Mosleh-Shirazi S (2023) An investigation into green synthesis of Ru template gold nanoparticles and the in vitro photothermal effect on the MCF-7 human breast cancer cell line. Appl Phys A 129:56410.1007/s00339-023-06832-6 ↗
17. Taylor ML, Wilson RE Jr, Amrhein KD, Huang X (2022) Gold nanorod-assisted photothermal therapy and improvement strategies. Bioengineering 9:20010.3390/bioengineering9050200 ↗
18. Malhotra S, Dumoga S, Sirohi P, Singh N (2019) Red blood cells-derived vesicles for delivery of lipophilic drug camptothecin. ACS Appl Mater Interfaces 11:22141–22151. https://doi.org/10.1021/acsami.9b0482710.1021/acsami.9b04827 ↗
19. Huang Q, Liu X, Wang H, Liu X, Zhang Q, Li K, Chen Y, Zhu Q, Shen Y, Sui M (2022) A nanotherapeutic strategy to overcome chemoresistance to irinotecan/7-ethyl-10-hydroxy-camptothecin in colorectal cancer. Acta Biomater 137:262–27510.1016/j.actbio.2021.10.034 ↗
20. McCarron PA, Marouf WM, Quinn DJ, Fay F, Burden RE, Olwill SA, Scott CJ (2008) Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells. Bioconjug Chem 19:1561–156910.1021/bc800057g ↗
21. Zeng Y, Chen H, Yang F, Li H, Yang P (2022) A feasible strategy of fabricating camptothecin (SN38)-loaded holmium ferrite nanocarrier delivery for glioma treatment. Mater Res Express 9:11501110.1088/2053-1591/ac9e8f ↗
22. Chi Y, Wang Z, Wang J, Dong W, Xin P, Bi J, Jiang T, Chen C-P (2020) Dimeric camptothecin-loaded mPEG-PCL nanoparticles with high drug loading and reduction-responsive drug release. Colloid Polym Sci 298:51–5810.1007/s00396-019-04581-8 ↗
23. Jeong EH, Jung G, Hong CA, Lee H (2014) Gold nanoparticle (AuNP)-based drug delivery and molecular imaging for biomedical applications. Arch Pharmacal Res 37:53–5910.1007/s12272-013-0273-5 ↗
24. Nikoobakht B, El-Sayed MA (2003) Preparation and growth mechanism of gold nanorods (NRs) using seed-mediated growth method. Chem Mater 15:1957–1962. https://doi.org/10.1021/cm020732l10.1021/cm020732l ↗
25. Ahmad I, Pandit J, Sultana Y, Mishra AK, Hazari PP, Aqil M (2019) Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: characterization, pharmacokinetic and deposition study. Mater Sci Eng, C 100:959–970. https://doi.org/10.1016/j.msec.2019.03.06010.1016/j.msec.2019.03.060 ↗
26. He K, Liu J, Gao Y, Hao Y, Yang X, Huang G (2020) Preparation and evaluation of stearylamine-bearing pemetrexed disodium-loaded cationic liposomes in vitro and in vivo. AAPS PharmSciTech 21:193. https://doi.org/10.1208/s12249-019-1586-610.1208/s12249-019-1586-6 ↗
27. Mohan N, Mohamed Subarkhan MK, Ramesh R (2018) Synthesis, antiproliferative activity and apoptosis-promoting effects of arene ruthenium(II) complexes with N, O chelating ligands. J Organometall Chem. https://doi.org/10.1016/j.jorganchem.2018.01.02210.1016/j.jorganchem.2018.01.022 ↗
28. Giriraj K, Mohamed Kasim MS, Balasubramaniam K, Thangavel SK, Venkatesan J, Suresh S, Shanmugam P, Karri C (2022) Various coordination modes of new coumarin Schiff bases toward Cobalt (III) ion: synthesis, spectral characterization, in vitro cytotoxic activity, and investigation of apoptosis. Appl Organometall Chem 36:6536. https://doi.org/10.1002/aoc.653610.1002/aoc.6536 ↗
29. Mohamed Kasim MS, Sundar S, Rengan R (2018) Synthesis and structure of new binuclear ruthenium(II) arene benzil bis(benzoylhydrazone) complexes: investigation on antiproliferative activity and apoptosis induction. Inorg Chem Front 5:585–596. https://doi.org/10.1039/c7qi00761b10.1039/c7qi00761b ↗
30. Dorairaj DP, Haribabu J, Dharmasivam M, Malekshah RE, Mohamed Subarkhan MK, Echeverria C, Karvembu R (2023) Ru(II)-p-cymene complexes of furoylthiourea ligands for anticancer applications against breast cancer cells. Inorg Chem 62:11761–11774. https://doi.org/10.1021/acs.inorgchem.3c0075710.1021/acs.inorgchem.3c00757 ↗
31. Balaji S, Mohamed Subarkhan MK, Ramesh R, Wang H, Semeril D (2020) Synthesis and structure of arene Ru(II) N∧O-chelating complexes: in vitro cytotoxicity and cancer cell death mechanism. Organometallics 39:1366–1375. https://doi.org/10.1021/acs.organomet.0c0009210.1021/acs.organomet.0c00092 ↗
32. Mohamed Subarkhan MK, Ren L, Xie B, Chen C, Wang Y, Wang H (2019) Novel tetranuclear ruthenium(II) arene complexes showing potent cytotoxic and antimetastatic activity as well as low toxicity in vivo. Eur J Med Chem. https://doi.org/10.1016/j.ejmech.2019.06.06110.1016/j.ejmech.2019.06.061 ↗
33. Pilliadugula R, Haribabu J, Mohamed Subarkhan MK, Echeverria C, Karvembu R, Gopalakrishnan N (2021) Effect of morphology and (Sn, Cr) doping on in vitro antiproliferation properties of hydrothermally synthesized 1D GaOOH nanostructures. J Sci: Adv Mater Dev 6:351–363. https://doi.org/10.1016/j.jsamd.2021.03.00310.1016/j.jsamd.2021.03.003 ↗
34. Wang Y, Jin J, Shu L, Li T, Lu S, Subarkhan MKM, Chen C, Wang H (2020) New organometallic ruthenium(II) compounds synergistically show cytotoxic, antimetastatic and antiangiogenic activities for the treatment of metastatic cancer. Chem A Eur J. 26:15170–15182. https://doi.org/10.1002/chem.20200297010.1002/chem.202002970 ↗
35. Subarkhan MKM, Ramesh R (2016) Ruthenium(ii) arene complexes containing benzhydrazone ligands: synthesis, structure and antiproliferative activity. Inorg Chem Front 3:1245–1255. https://doi.org/10.1039/C6QI00197A10.1039/C6QI00197A ↗
36. Swaminathan S, Haribabu J, Mohamed Subarkhan MK, Manonmani G, Senthilkumar K, Balakrishnan N, Bhuvanesh N, Echeverria C, Karvembu R (2022) Coordination behavior of acylthiourea ligands in their Ru(II)–benzene complexes─structures and anticancer activity. Organometallics 41:1621–1630. https://doi.org/10.1021/acs.organomet.2c0012710.1021/acs.organomet.2c00127 ↗
37. Mohamed Subarkhan MK, Ramesh R, Liu Y (2016) Synthesis and molecular structure of arene ruthenium(II) benzhydrazone complexes: Impact of substitution at the chelating ligand and arene moiety on antiproliferative activity. New J Chem. https://doi.org/10.1039/c6nj01936f10.1039/c6nj01936f ↗
38. Swaminathan S, Haribabu J, Mohamed Subarkhan MK, Gayathri D, Balakrishnan N, Bhuvanesh N, Echeverria C, Karvembu R (2021) Impact of aliphatic acyl and aromatic thioamide substituents on the anticancer activity of Ru(ii)-p-cymene complexes with acylthiourea ligands—in vitro and in vivo studies. Dalton Trans 50:16311–16325. https://doi.org/10.1039/D1DT02611A10.1039/D1DT02611A ↗
39. Kalaiarasi G, Mohamed Subarkhan M, Fathima Safwana CK, Sruthi S, Sathiya Kamatchi T, Keerthana B, Ashok Kumar SL (2022) New organoruthenium(II) complexes containing N, X-donor (X = O, S) heterocyclic chelators: Synthesis, spectral characterization, in vitro cytotoxicity and apoptosis investigation. Inorg Chim Acta 535:120863. https://doi.org/10.1016/j.ica.2022.12086310.1016/j.ica.2022.120863 ↗
40. Sathiya Kamatchi T, Mohamed Subarkhan MK, Ramesh R, Wang H, Małecki JG (2020) Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes. Dalton Trans 49:11385–11395. https://doi.org/10.1039/D0DT01476A10.1039/D0DT01476A ↗
41. Raj Kumar R, Mohamed Subarkhan MK, Ramesh R (2015) Synthesis and structure of Nickel(ii) thiocarboxamide complexes: effect of ligand substitutions on DNA/protein binding, antioxidant and cytotoxicity. RSC Adv 5:46760–46773. https://doi.org/10.1039/C5RA06112A10.1039/C5RA06112A ↗
42. Zhang H, Liang Z, Zhang J, Wang W, Zhang H, Lu Q (2020) Zinc oxide nanoparticle synthesized from Euphorbia fischeriana root inhibits the cancer cell growth through modulation of apoptotic signaling pathways in lung cancer cells. Arab J Chem 13:6174–6183. https://doi.org/10.1016/j.arabjc.2020.05.02010.1016/j.arabjc.2020.05.020 ↗
43. Ghosh S, Roy A, Singhania A, Chatterjee S, Swarnakar S, Fujita D, Bandyopadhyay A (2018) In-vivo & in-vitro toxicity test of molecularly engineered PCMS: a potential drug for wireless remote controlled treatment. Toxicol Rep 5:1044–1052. https://doi.org/10.1016/j.toxrep.2018.10.01110.1016/j.toxrep.2018.10.011 ↗
44. Derakhshani A, Hesaraki S, Nezafati N, Azami M (2022) Wound closure, angiogenesis and antibacterial behaviors of tetracalcium phosphate/hydroxyethyl cellulose/hyaluronic acid/gelatin composite dermal scaffolds. J Biomater Sci Polym Ed 33:605–626. https://doi.org/10.1080/09205063.2021.200878610.1080/09205063.2021.2008786 ↗
45. Haalboom M, Blokhuis-Arkes MHE, Beuk RJ, Meerwaldt R, Klont R, Schijffelen MJ, Bowler PB, Burnet M, Sigl E, van der Palen JAM (2019) Culture results from wound biopsy versus wound swab: Does it matter for the assessment of wound infection? Clin Microbiol Infect 25:629-e710.1016/j.cmi.2018.08.012 ↗
46. Chen M, Tian J, Liu Y, Cao H, Li R, Wang J, Wu J, Zhang Q (2019) Dynamic covalent constructed self-healing hydrogel for sequential delivery of antibacterial agent and growth factor in wound healing. Chem Eng J 373:413–424. https://doi.org/10.1016/j.cej.2019.05.04310.1016/j.cej.2019.05.043 ↗
47. Hernandez-Adame L, Angulo C, Delgado K, Schiavone M, Castex M, Palestino G, Betancourt-Mendiola L, Reyes-Becerril M (2019) Biosynthesis of β-d-glucan-gold nanoparticles, cytotoxicity and oxidative stress in mouse splenocytes. Int J Biol Macromol 134:379–389. https://doi.org/10.1016/j.ijbiomac.2019.05.06510.1016/j.ijbiomac.2019.05.065 ↗
48. Kasibhatla S, Amarante-Mendes GP, Finucane D, Brunner T, Bossy-Wetzel E, Green DR (2006) Acridine orange/ethidium bromide (AO/EB) staining to detect apoptosis. CSH Protocols 2006:799–803. https://doi.org/10.1101/pdb.prot449310.1101/pdb.prot4493 ↗
49. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T (2003) In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 24:1121–1131. https://doi.org/10.1016/S0142-9612(02)00445-310.1016/S0142-9612(02)00445-3 ↗
50. Zuo W, Chen D, Fan Z, Chen L, Zhu Z, Zhu Q, Zhu X (2020) Design of light/ROS cascade-responsive tumor-recognizing nanotheranostics for spatiotemporally controlled drug release in locoregional photo-chemotherapy. Acta Biomater 111:327–340. https://doi.org/10.1016/j.actbio.2020.04.05210.1016/j.actbio.2020.04.052 ↗